Comparative effectiveness of mesenchymal stem cell versus bone-marrow mononuclear cell transplantation in heart failure: a meta-analysis of randomized controlled trials.

Stem Cell Res Ther · 2024 · PMC11227704 · PMID 38971816

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

Although the RR of mortality was marginally significant, BMMNC and MSC therapy could not decrease the risk of mortality in the longest follow-up period (BMMNC: RR (95% CI) = 0.84 (0.54, 1.32), MSC: RR (95% CI) = 0.83 (0.69, 1.01), between-subgroup p = 0.96).

also in 26,082 other papers

marginally non-significantno p-value reported

Regarding the distance walked during 6MWT, stem cell group could increase the distance of 6MWT by 21.9 m but this difference was marginally non-significant.

also in 1,493 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.